Fantastic news about Scotland’s TC BioPharm (TCB), the first-ever Investing Women backed business, which has entered a strategic collaboration with Massachusetts company bluebird bio Inc. The deal includes a $16m upfront payment for TCB and potential for further R&D and commercial milestone payments as well as tiered royalties on product sales.
In 2015 Investing Women led a £1.2m equity and grand funding to help the Lanarkshire-based company start its first treatment of UK patients with melanoma, lung and kidney cancers. Investing Women’s Lorraine Porter, a successful oil and gas entrepreneur, also serves on TCB’s board as non-executive director.
This is great news for both TCB and the Scottish life sciences sector. More details are here >>